Pandeya Prakash Raj, Lamichhane Ramakanta, Lamichhane Gopal, Lee Kyung-Hee, Lee Hyeong Kyu, Rhee Su-Jin, Jung Hyun-Ju
Department of Oriental Pharmacy and Wonkwang-Oriental Medicines Research Institute, Wonkwang University, Iksan, South Korea.
Bio-Safety Research Institute, Jeonbuk National University, Iksan, South Korea.
Front Pharmacol. 2021 Dec 17;12:807081. doi: 10.3389/fphar.2021.807081. eCollection 2021.
Obesity is a life-threatening metabolic disorder necessitating urgent development of safe and effective therapy. Currently, limited such therapeutic measures are available for obesity. The present study was designed to develop a novel, safe and effective herbal therapy for the management of obesity. A polyherbal formulation (18KHT01) was developed by homogeneously mixing a specific proportion of crude (acorn jelly powder), (dry leaf buds), and (dry aerial part) along with (fruit juice). Synergistic antioxidant, antiadipogenic, and anti-obesity activities were evaluated by as well as studies. experiments revealed strong synergistic antioxidant and anti-adipogenic activities of 18KHT01. Molecular assessment of 18KHT01 showed significant down-regulation of vital adipogenic factors such as PPARγ, C/EBPα, aP2, SREBP-1c, FAS, and LPL. Based on the results of the preliminary toxicity study, 75 and 150 mg/kg, twice daily doses of 18KHT01 were administered to evaluate anti-obesity activity in diet-induced obese (DIO) C57BL/6J mice model. The major obesity-related parameters such as body weight, weight gain, food efficiency ratio, as well as serum lipid profile were significantly reduced by 18KHT01 with potential synergism. Also, the high-fat diet-induced insulin resistance was suggestively alleviated by the formulation, and thus ameliorated fasting blood glucose. Histological evaluation of liver and white adipose tissue revealed that the significant reduction of fat depositions and thus reduction of these tissue weights. Synergy evaluation experiments exhibited that the 18KHT01 offered strong synergism by improving efficacy and reducing the toxicity of its ingredients. Overall results evidenced the 18KHT01 as a safe and potent anti-obesity herbal therapy.
肥胖是一种危及生命的代谢紊乱疾病,迫切需要开发安全有效的治疗方法。目前,针对肥胖的此类治疗措施有限。本研究旨在开发一种用于治疗肥胖的新型、安全有效的草药疗法。通过将特定比例的粗品(橡子冻干粉)、(干叶芽)和(地上干燥部分)与(果汁)均匀混合,开发出一种多草药配方(18KHT01)。通过以及研究评估了协同抗氧化、抗脂肪生成和抗肥胖活性。实验揭示了18KHT01具有强大的协同抗氧化和抗脂肪生成活性。对18KHT01的分子评估显示,重要的脂肪生成因子如PPARγ、C/EBPα、aP2、SREBP-1c、FAS和LPL显著下调。基于初步毒性研究结果,对饮食诱导肥胖(DIO)的C57BL/6J小鼠模型给予每日两次、剂量为75和150 mg/kg的18KHT01,以评估其抗肥胖活性。18KHT01显著降低了体重、体重增加、食物效率比以及血脂谱等主要肥胖相关参数,并具有潜在的协同作用。此外,该配方还提示性地减轻了高脂饮食诱导的胰岛素抵抗,从而改善了空腹血糖。肝脏和白色脂肪组织的组织学评估显示,脂肪沉积显著减少,这些组织的重量也随之减轻。协同作用评估实验表明,18KHT01通过提高疗效和降低其成分的毒性提供了强大的协同作用。总体结果证明18KHT01是一种安全有效的抗肥胖草药疗法。